Hospital study probes reversal drug for bleeding on blood thinners

NCT ID NCT07333144

Recruiting now Knowledge-focused Sponsor: University Hospital, Strasbourg, France Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how doctors at Strasbourg University Hospital manage severe stomach or intestinal bleeding in patients taking blood thinners (DOACs). Researchers will review medical records of 250 adults to see how often a drug called prothrombin complex concentrate is used to reverse the blood thinner's effects. The goal is to gather real-world data on current practices and outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: prothrombin complex concentrate
What this could lead to: If successful, this study could clarify whether prothrombin complex concentrate is effective and safe for reversing blood thinners during severe gastrointestinal bleeding.
What could go wrong: This is an observational study, not a controlled trial, so it cannot prove cause and effect. The results may be limited by how doctors chose treatments in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL BLEEDING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Gastrointestinal Hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTROINTESTINAL BLEEDING

Contacts and locations

Locations

Service des Urgences Adultes - CHU de Strasbourg - France
RECRUITING

Strasbourg, 67091, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.